8-129673211-T-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NR_130917.1(CCDC26):n.312+6717A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: NR_130917.1 is not a MANE Select or MANE Plus Clinical transcript for CCDC26; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.174 (AC=26,492) in the gnomAD database across 152,204 control chromosomes, including 2,405 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.226. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2405 hom., cov: 32)

Consequence

CCDC26
NR_130917.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.08

Publications

74 publications found
Variant links:
Genes affected
CCDC26 (HGNC:28416): (CCDC26 long non-coding RNA) Implicated in brain cancer and high grade glioma. [provided by Alliance of Genome Resources, Jul 2025]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_130917.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.2255 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NR_130917.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CCDC26 NR_130917.1
HGVSc / HGVSpn.312+6717A>C
Exon rankIntron 1 of 3
intron
Prot:

Ensembl Transcripts

CCDC26 ENST00000446592.7
TSL:1
HGVSc / HGVSpn.312+6717A>C
Exon rankIntron 1 of 3
intron
Prot:
CCDC26 ENST00000642958.2
HGVSc / HGVSpn.374-4913A>C
Exon rankIntron 2 of 3
intron
Prot:
CCDC26 ENST00000645432.1
HGVSc / HGVSpn.363+6717A>C
Exon rankIntron 2 of 2
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.174
AC:26448
Hom:2390
AN:152086
Cov:32
GnomAD4 genome
AF: 0.174
AC:26492
Hom:2405
AN:152204
Cov:32
TOPMed (Bravo)
AF: 0.178
AC:46994
Hom:4442
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.173
AC:110495
Hom:9913
AN:640248
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.163
AC:381
Hom:34
AN:2342
ChinaMAP Phase 1
AF: 0.264
Denmark Genome
AF: 0.200
AC:60
AN:300
GenomeAsia100K
AF: 0.185
AC:646
AN:3478
Korea4K (4,157 Koreans)
AF: 0.255
AC:1846
AN:7232
Qatari Genome
AF: 0.210
AC:37
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.214
AC:26278
Hom:2898
AN:122750
Turkish Variome
AF: 0.152
AC:235
Hom:17
AN:1546
UK10K
AF: 0.171
AC:1293
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.259
AC:2319
Hom:320
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign0.11
BayesDel_noAF
Benign-0.95
CADD
Benign0.059
DANN
Benign0.50
GPN-Star LLR
N/A-1.6
GPN-Star score
N/A1.6
PhyloP100
Benign-2.1
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.